Impulse Dynamics vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Impulse Dynamics makes the Optimizer Smart Mini, the first FDA-approved device for Cardiac Contractility Modulation (CCM) therapy in NYHA Class III heart failure patients; conducting AIM HIGHer RCT targeting expanded indication (LVEF 40–60%).
About
Impulse Dynamics is a medical device company founded in 1996 that developed and commercialized Cardiac Contractility Modulation (CCM®) therapy — a proprietary approach to treating chronic heart failure that is distinct from pacemakers, ICDs, or cardiac resynchronization therapy (CRT). CCM therapy delivers precisely timed, high-energy electrical signals to the right ventricle during the absolute refractory period, when the heart cannot be paced. These signals do not alter heart rhythm but instead improve the contractile force of cardiac muscle — addressing the fundamental mechanical impairment of heart failure.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.